S-Amisulpride
CAS: 71675-92-8
Ref. 3D-WCA67592
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Product Information
- 4-Amino-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-5-(ethylsulfonyl)-2-methoxybenzamide
- Benzamide,4-amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(ethylsulfonyl)-2-methoxy-, (S)-
- Esamisulpride
- S-(-)-Amisulpride
S-Amisulpride is a benzamide antipsychotic drug that is an atypical antipsychotic. It has been shown to be effective in the treatment of schizophrenia, schizoaffective disorder, and bipolar disorder. Amisulpride was first synthesized by a French company called Laboratoires Servier and it was approved for sale in France in 1988. The drug is available as tablets for oral administration. The clinical effects of amisulpride are due to its ability to block dopamine receptors and serotonin receptors, which are neurotransmitters that play a role in the regulation of mood. Amisulpride also has stereoselective properties as it is active as an antipsychotic only when administered in the S-enantiomer form.
Chemical properties
Technical inquiry about: 3D-WCA67592 S-Amisulpride
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
